These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4736648

  • 1. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K, Izumi K, Iwai H, Takeyama S.
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract] [Full Text] [Related]

  • 2. Lentysine: a new hypolipidemic agent from a mushroom.
    Rokujo T, Kikuchi H, Tensho A, Tsukitani Y, Takenawa T, Yoshida K, Kamiya T.
    Life Sci; 1970 Apr 08; 9(7):379-85. PubMed ID: 5463059
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and hypocholesterolemic activities of eritadenine derivatives.
    Okumura K, Matsumoto K, Fukamizu M, Yasuo H, Taguchi Y.
    J Med Chem; 1974 Aug 08; 17(8):846-55. PubMed ID: 4845378
    [No Abstract] [Full Text] [Related]

  • 4. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C, Edwards KD, Paoletti R.
    Life Sci II; 1970 May 08; 9(9):523-34. PubMed ID: 5452796
    [No Abstract] [Full Text] [Related]

  • 5. Correlation of suppressed linoleic acid metabolism with the hypocholesterolemic action of eritadenine in rats.
    Sugiyama K, Yamakawa A, Saeki S.
    Lipids; 1997 Aug 08; 32(8):859-66. PubMed ID: 9270978
    [Abstract] [Full Text] [Related]

  • 6. Hypocholesterolemic action of eritadenine is mediated by a modification of hepatic phospholipid metabolism in rats.
    Sugiyama K, Akachi T, Yamakawa A.
    J Nutr; 1995 Aug 08; 125(8):2134-44. PubMed ID: 7643248
    [Abstract] [Full Text] [Related]

  • 7. Dietary eritadenine-induced alteration of molecular species composition of phospholipids in rats.
    Sugiyama K, Yamakawa A.
    Lipids; 1996 Apr 08; 31(4):399-404. PubMed ID: 8743052
    [Abstract] [Full Text] [Related]

  • 8. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
    Duncan CH, Best MM.
    Atherosclerosis; 1973 Apr 08; 17(2):161-6. PubMed ID: 4709117
    [No Abstract] [Full Text] [Related]

  • 9. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR, Kelly LA, Ho RS, Trapold JH.
    Biochem Pharmacol; 1969 Aug 08; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
    Barrett AM, Thorp JM.
    Br J Pharmacol Chemother; 1968 Feb 08; 32(2):381-91. PubMed ID: 4296427
    [No Abstract] [Full Text] [Related]

  • 11. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO, Friedman M.
    Atherosclerosis; 1970 Feb 08; 11(3):373-82. PubMed ID: 5433083
    [No Abstract] [Full Text] [Related]

  • 12. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D, Tepper SA, Sallata P, Kabakjian JR, Cristofalo VJ.
    Proc Soc Exp Biol Med; 1969 Oct 08; 132(1):79-82. PubMed ID: 5344871
    [No Abstract] [Full Text] [Related]

  • 13. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW, Sefranka JA, McIntosh DD.
    Am J Clin Nutr; 1970 Sep 08; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract] [Full Text] [Related]

  • 14. Effect of administration of clofibrate and clofenapate on the content and distribution of ubiquinone in rat tissues.
    Krishnakantha TP, Kurup CK.
    Indian J Biochem Biophys; 1974 Mar 08; 11(1):51-3. PubMed ID: 4435808
    [No Abstract] [Full Text] [Related]

  • 15. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP, Kurup CK.
    Indian J Biochem Biophys; 1973 Sep 08; 10(3):224-7. PubMed ID: 4792935
    [No Abstract] [Full Text] [Related]

  • 16. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
    Klebanov BM.
    Farmakol Toksikol; 1970 Sep 08; 33(3):324-7. PubMed ID: 5453029
    [No Abstract] [Full Text] [Related]

  • 17. [Hypocholesterolemic activity of analogous compounds related to eritadenine, an active component of shiitake, Lentinus edodes Sing (author's transl)].
    Tensho A, Shimizu I, Takenawa T, Kikuchi H, Rokujo T.
    Yakugaku Zasshi; 1974 Jun 08; 94(6):708-16. PubMed ID: 4472979
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterol-free and cholesterol-enriched diets.
    Shimada Y, Morita T, Sugiyama K.
    Biosci Biotechnol Biochem; 2003 May 08; 67(5):996-1006. PubMed ID: 12834276
    [Abstract] [Full Text] [Related]

  • 20. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC, Connor WE, Armstrong ML, Warner ED.
    Lab Invest; 1968 Oct 08; 19(4):370-5. PubMed ID: 5699117
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.